<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03214406</url>
  </required_header>
  <id_info>
    <org_study_id>ST-7323</org_study_id>
    <nct_id>NCT03214406</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of the Efficacy of a Marketed Dentifrice on Plaque and Gingivitis</brief_title>
  <official_title>Clinical Evaluation of the Efficacy of a Marketed Dentifrice on Plaque and Gingivitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Church &amp; Dwight Company, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Church &amp; Dwight Company, Inc.</source>
  <brief_summary>
    <textblock>
      Parallel, double blind, randomized, Institutional Review Board (IRB) -approved study
      involving approximately 160 subjects to complete. Subjects were randomly assigned to either
      the test product (Arm &amp; Hammer Advance White Brilliant Sparkle) or the control (Crest Cavity
      Protection Regular) based on baseline mean whole-mouth plaque and gingival scores and
      age.Subjects brushed with their assigned dentifrice two times (2X) daily and were evaluated
      for gingivitis, bleeding and plaque at Baseline and after 4-, 8-, and 12-weeks of product
      use. Return to pre-study hygiene regimen for 4 weeks and final evaluation at 16 weeks.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 8, 2010</start_date>
  <completion_date type="Actual">August 3, 2010</completion_date>
  <primary_completion_date type="Actual">August 3, 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Within-Treatment Whole-Mouth Differences (vs Baseline) - Gingival Efficacy</measure>
    <time_frame>16 weeks</time_frame>
    <description>change in score as measured by Gingival Index (0=absence of inflammation, 1=mild inflammation: slight change in color, little change in texture of any portion of but not the entire marginal or papillary gingival unit, 2=mild inflammation: slight change in color, little change in texture to entire marginal or papillary gingival unit, 3=moderate inflammation: glazing, redness, edema and/or hypertrophy of the marginal or papillary gingival unit, 4=severe inflammation: marked redness, edema and/or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration. The scale ranges from 0-4.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Within-Treatment Whole-Mouth Differences (vs Baseline) Gingival Bleeding Efficacy</measure>
    <time_frame>16 weeks</time_frame>
    <description>change in score as measured by Gingival Bleeding Index (0=absence of bleeding after 30 seconds, 1= bleeding observed after 30 seconds, 2= bleeding occurs instantly). The scale ranges from 0-2.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Within-Treatment Whole-Mouth Differences (vs Baseline) - Plaque Efficacy</measure>
    <time_frame>16 weeks</time_frame>
    <description>change in score as measured by Plaque Index (0=no visible plaque, 1=separate flecks of plaque at the cervical margin of the tooth, 2=a thin, continuous band of plaque (up to 1mm wide) at the cervical margin, 3= a band of plaque wider than 1 mm but covering less than one-third of the crown, 4=plaque covering at least one-third but less than two-thirds of the crown, 5= plaque covering two-thirds or more of the crown. The scale ranges from 0-5.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">181</enrollment>
  <condition>Plaque</condition>
  <condition>Gingivitis</condition>
  <arm_group>
    <arm_group_label>Arm &amp; Hammer Advance White Brilliant Sparkle (Test product)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2X daily brushing for 12 weeks with Arm &amp; Hammer Advance White Brilliant Sparkle (Test product). Return to pre-study hygiene regimen for 4 weeks and final evaluation at 16 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Crest Cavity Protection Regular Toothpaste (Negative Control)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2X daily brushing for 12 weeks with Crest Cavity Protection Regular Toothpaste (Negative Control). Return to pre-study hygiene regimen for 4 weeks and final evaluation at 16 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Arm &amp; Hammer Advance White Brilliant Sparkle (Test product)</intervention_name>
    <description>20% sodium bicarbonate</description>
    <arm_group_label>Arm &amp; Hammer Advance White Brilliant Sparkle (Test product)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Crest Cavity Protection Regular Toothpaste (Negative Control)</intervention_name>
    <description>Negative control</description>
    <arm_group_label>Crest Cavity Protection Regular Toothpaste (Negative Control)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have provided written informed consent prior to being entered into study

          -  Have at least 18 scorable natural teeth as determined by the examiner

          -  Have a mean baseline plaque index score greater than or equal to 2.0 as determined by
             the Soparkar Modification of the Turesky modification of the Quigley-Hein Plaque Index

          -  Have a mean baseline gingival index score of greater than 1.80 as determined by the
             Modified Gingival Index

          -  Presence of greater than 10 bleeding sites upon probing

          -  Agree not to have dental prophylaxis or any other elective, no -emergency dental
             procedures (other than those provided during the study) any time during the study

          -  Agree to abstain from use of floss, chewing gum, mouth rinses, any toothpaste other
             than the study toothpaste, tooth whitening products (either professional or at home
             use) and all other oral hygiene other than the study procedures for the duration of
             the study.

          -  Agree to refrain from all oral hygiene on the morning of each evaluation visit and to
             refrain from eating and drinking for 4 hours prior to each evaluation visit

          -  Agree to comply with the conditions and schedule of the study

        Exclusion Criteria:

          -  Physical limitations or restrictions that might preclude normal tooth brushing

          -  Evidence of gross oral pathology, including widespread caries or chronic neglect,
             extensive restoration, pre-existing gross plaque or soft or hard tissue tumor of the
             oral cavity.

          -  Heavy calculus that might interfere with evaluations as determined by the
             Investigator/Examiner

          -  Chronic disease with concomitant oral manifestations

          -  Conditions requiring antibiotic prophylaxis prior to invasive procedures, such as
             heart murmur, history of rheumatic fever, valvular disease or certain prosthetic
             implants

          -  History of uncontrolled diabetes or hepatic or renal disease, or other serious
             conditions or transmittable diseases (eg cardiovascular disease, AIDS)

          -  Subjects with fixed or removable orthodontic appliances or removable partial dentures

          -  Subjects who are currently undergoing, or require, extensive dental work or
             orthodontic treatment

          -  Treatment with antibiotics within the 1-month period before the baseline examination,
             or a condition that is likely to require antibiotic treatment over the course of the
             trial

          -  Chronic treatment (2 weeks or more) with any medication known to affect periodontal
             status (including phenytoin, calcium antagonists, cyclosporine, coumarin, nonsteroidal
             anti-inflammatory drugs, and aspirin) within 1 month of baseline examination. All
             other medications for chronic medical conditions must have been initiated at least 3
             months before enrollment

          -  Moderately advanced to advanced periodontitis as indicated by clinical attachment
             loss, radiographic alveolar bone loss, and/or periodontal pockets greater than 5
             millimeters

          -  Having history of early-onset periodontitis or acute necrotizing ulcerative gingivitis

          -  Concomitant endodontic or periodontal therapy other than prophylaxis in the last 6
             months

          -  Professional prophylaxis within 1 month prior to the baseline clinical evaluation

          -  Currently using bleaching trays

          -  Currently using power toothbrush

          -  Currently a smoker or recently (during the past 6 months) quit smoking

          -  Having any oral piercings in or around the oral cavity with ornament or accessory

          -  Regular use of any chemotherapeutic antiplaque/antigingivitis products such as Colgate
             Total, Crest Pro-Health, Listerine, etc

          -  History of significant adverse effects following use of oral hygiene products such as
             toothpastes and mouthrinses

          -  Subjects who are nursing, pregnant or plan to become pregnant for the duration of the
             study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>BioSci Research Canada, Ltd</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <zip>L5N 1A4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 10, 2017</study_first_submitted>
  <study_first_submitted_qc>July 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 11, 2017</study_first_posted>
  <results_first_submitted>July 13, 2017</results_first_submitted>
  <results_first_submitted_qc>July 22, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">July 23, 2019</results_first_posted>
  <last_update_submitted>July 22, 2019</last_update_submitted>
  <last_update_submitted_qc>July 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gingivitis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Arm &amp; Hammer Advance White Brilliant Sparkle (Test Product)</title>
          <description>2X daily brushing for 12 weeks with Arm &amp; Hammer Advance White Brilliant Sparkle (Test product)
Arm &amp; Hammer Advance White Brilliant Sparkle (Test product): 20% sodium bicarbonate</description>
        </group>
        <group group_id="P2">
          <title>Crest Cavity Protection Regular Toothpaste (Negative Control)</title>
          <description>2X daily brushing for 12 weeks with Crest Cavity Protection Regular Toothpaste (Negative Control)
Crest Cavity Protection Regular Toothpaste (Negative Control): Negative control</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="88"/>
                <participants group_id="P2" count="93"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="78"/>
                <participants group_id="P2" count="78"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>did not meet enrollment criteria</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Arm &amp; Hammer Advance White Brilliant Sparkle (Test Product)</title>
          <description>2X daily brushing for 12 weeks with Arm &amp; Hammer Advance White Brilliant Sparkle (Test product)
Arm &amp; Hammer Advance White Brilliant Sparkle (Test product): 20% sodium bicarbonate</description>
        </group>
        <group group_id="B2">
          <title>Crest Cavity Protection Regular Toothpaste (Negative Control)</title>
          <description>2X daily brushing for 12 weeks with Crest Cavity Protection Regular Toothpaste (Negative Control)
Crest Cavity Protection Regular Toothpaste (Negative Control): Negative control</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="78"/>
            <count group_id="B2" value="78"/>
            <count group_id="B3" value="156"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="78"/>
                    <count group_id="B2" value="78"/>
                    <count group_id="B3" value="156"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="78"/>
                    <measurement group_id="B2" value="78"/>
                    <measurement group_id="B3" value="156"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="78"/>
                    <count group_id="B2" value="78"/>
                    <count group_id="B3" value="156"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="107"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gingvial Efficacy</title>
          <description>Lobene Modified Loe-Silness Gingival Scoring Index (MGI) - gingival sites were visually scored at each visit on the buccal and lingual marginal gingivae and interdental papillae of all scorable teeth, using a scale of 0-4. Lower values represent a better outcome.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="78"/>
                    <count group_id="B2" value="78"/>
                    <count group_id="B3" value="156"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.039" spread=".053"/>
                    <measurement group_id="B2" value="2.039" spread=".057"/>
                    <measurement group_id="B3" value="2.039" spread=".055"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gingival Bleeding Efficacy</title>
          <description>Bleeding was assessed on all scorable buccal and lingual surfaces by inserting a periodontal probe into the gingival crevice and sweeping from the distal aspect to the mesial aspect around the tooth at a depth of approximately 1 mm and angle of approximately 60 degrees while in contact with the sulcular epithelium. Three areas (distobuccal, midbuccal and midlingual) were assessed around each tooth. Sites were scored at each visit using the Gingival Bleeding Index (GBI) as defined by Saxton and van der Ouderaa on a scale of 0-2. Lower values represent a better outcome.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="78"/>
                    <count group_id="B2" value="78"/>
                    <count group_id="B3" value="156"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value=".228" spread=".046"/>
                    <measurement group_id="B2" value=".230" spread=".044"/>
                    <measurement group_id="B3" value=".229" spread=".045"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Plaque Efficacy</title>
          <description>Plaque was scored at each visit using the Soparker modification of the Turesky Modification of the Quigley-Hein Plaque Index (PI) on all scorable buccal and lingual surfaces. Plaque was stained with disclosant and each tooth was divided into six areas for scoring on a scale of 0-5. A PI score for each subject was calculated by adding all individual site scores (6 per tooth) and dividing by the total number of sites scored (teeth x 6). Lower values represent a better outcome.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="78"/>
                    <count group_id="B2" value="78"/>
                    <count group_id="B3" value="156"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.575" spread=".295"/>
                    <measurement group_id="B2" value="2.534" spread=".248"/>
                    <measurement group_id="B3" value="2.555" spread=".272"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Within-Treatment Whole-Mouth Differences (vs Baseline) - Gingival Efficacy</title>
        <description>change in score as measured by Gingival Index (0=absence of inflammation, 1=mild inflammation: slight change in color, little change in texture of any portion of but not the entire marginal or papillary gingival unit, 2=mild inflammation: slight change in color, little change in texture to entire marginal or papillary gingival unit, 3=moderate inflammation: glazing, redness, edema and/or hypertrophy of the marginal or papillary gingival unit, 4=severe inflammation: marked redness, edema and/or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration. The scale ranges from 0-4.</description>
        <time_frame>16 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm &amp; Hammer Advance White Brilliant Sparkle (Test Product)</title>
            <description>2X daily brushing for 12 weeks with Arm &amp; Hammer Advance White Brilliant Sparkle (Test product)
Arm &amp; Hammer Advance White Brilliant Sparkle (Test product): 20% sodium bicarbonate</description>
          </group>
          <group group_id="O2">
            <title>Crest Cavity Protection Regular Toothpaste (Negative Control)</title>
            <description>2X daily brushing for 12 weeks with Crest Cavity Protection Regular Toothpaste (Negative Control)
Crest Cavity Protection Regular Toothpaste (Negative Control): Negative control</description>
          </group>
        </group_list>
        <measure>
          <title>Within-Treatment Whole-Mouth Differences (vs Baseline) - Gingival Efficacy</title>
          <description>change in score as measured by Gingival Index (0=absence of inflammation, 1=mild inflammation: slight change in color, little change in texture of any portion of but not the entire marginal or papillary gingival unit, 2=mild inflammation: slight change in color, little change in texture to entire marginal or papillary gingival unit, 3=moderate inflammation: glazing, redness, edema and/or hypertrophy of the marginal or papillary gingival unit, 4=severe inflammation: marked redness, edema and/or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration. The scale ranges from 0-4.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="78"/>
                <count group_id="O2" value="78"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>4 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".230" spread=".105"/>
                    <measurement group_id="O2" value=".155" spread=".123"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".3701" spread=".130"/>
                    <measurement group_id="O2" value=".205" spread=".077"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".444" spread=".139"/>
                    <measurement group_id="O2" value=".214" spread=".110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>16 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".330" spread=".118"/>
                    <measurement group_id="O2" value=".157" spread=".084"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Within-Treatment Whole-Mouth Differences (vs Baseline) Gingival Bleeding Efficacy</title>
        <description>change in score as measured by Gingival Bleeding Index (0=absence of bleeding after 30 seconds, 1= bleeding observed after 30 seconds, 2= bleeding occurs instantly). The scale ranges from 0-2.</description>
        <time_frame>16 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm &amp; Hammer Advance White Brilliant Sparkle (Test Product)</title>
            <description>2X daily brushing for 12 weeks with Arm &amp; Hammer Advance White Brilliant Sparkle (Test product)
Arm &amp; Hammer Advance White Brilliant Sparkle (Test product): 20% sodium bicarbonate</description>
          </group>
          <group group_id="O2">
            <title>Crest Cavity Protection Regular Toothpaste (Negative Control)</title>
            <description>2X daily brushing for 12 weeks with Crest Cavity Protection Regular Toothpaste (Negative Control)
Crest Cavity Protection Regular Toothpaste (Negative Control): Negative control</description>
          </group>
        </group_list>
        <measure>
          <title>Within-Treatment Whole-Mouth Differences (vs Baseline) Gingival Bleeding Efficacy</title>
          <description>change in score as measured by Gingival Bleeding Index (0=absence of bleeding after 30 seconds, 1= bleeding observed after 30 seconds, 2= bleeding occurs instantly). The scale ranges from 0-2.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="78"/>
                <count group_id="O2" value="78"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>4 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".134" spread=".055"/>
                    <measurement group_id="O2" value=".119" spread=".056"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".162" spread=".042"/>
                    <measurement group_id="O2" value=".145" spread=".039"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".190" spread=".045"/>
                    <measurement group_id="O2" value=".162" spread=".056"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>16 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".180" spread=".043"/>
                    <measurement group_id="O2" value=".144" spread=".056"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Within-Treatment Whole-Mouth Differences (vs Baseline) - Plaque Efficacy</title>
        <description>change in score as measured by Plaque Index (0=no visible plaque, 1=separate flecks of plaque at the cervical margin of the tooth, 2=a thin, continuous band of plaque (up to 1mm wide) at the cervical margin, 3= a band of plaque wider than 1 mm but covering less than one-third of the crown, 4=plaque covering at least one-third but less than two-thirds of the crown, 5= plaque covering two-thirds or more of the crown. The scale ranges from 0-5.</description>
        <time_frame>16 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm &amp; Hammer Advance White Brilliant Sparkle (Test Product)</title>
            <description>2X daily brushing for 12 weeks with Arm &amp; Hammer Advance White Brilliant Sparkle (Test product)
Arm &amp; Hammer Advance White Brilliant Sparkle (Test product): 20% sodium bicarbonate</description>
          </group>
          <group group_id="O2">
            <title>Crest Cavity Protection Regular Toothpaste (Negative Control)</title>
            <description>2X daily brushing for 12 weeks with Crest Cavity Protection Regular Toothpaste (Negative Control)
Crest Cavity Protection Regular Toothpaste (Negative Control): Negative control</description>
          </group>
        </group_list>
        <measure>
          <title>Within-Treatment Whole-Mouth Differences (vs Baseline) - Plaque Efficacy</title>
          <description>change in score as measured by Plaque Index (0=no visible plaque, 1=separate flecks of plaque at the cervical margin of the tooth, 2=a thin, continuous band of plaque (up to 1mm wide) at the cervical margin, 3= a band of plaque wider than 1 mm but covering less than one-third of the crown, 4=plaque covering at least one-third but less than two-thirds of the crown, 5= plaque covering two-thirds or more of the crown. The scale ranges from 0-5.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="78"/>
                <count group_id="O2" value="78"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>4 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".648" spread=".327"/>
                    <measurement group_id="O2" value=".468" spread=".264"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".776" spread=".369"/>
                    <measurement group_id="O2" value=".574" spread=".283"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".765" spread=".295"/>
                    <measurement group_id="O2" value=".533" spread=".332"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>16 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".275" spread=".378"/>
                    <measurement group_id="O2" value=".275" spread=".378"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Arm &amp; Hammer Advance White Brilliant Sparkle (Test Product)</title>
          <description>2X daily brushing for 12 weeks with Arm &amp; Hammer Advance White Brilliant Sparkle (Test product)
Arm &amp; Hammer Advance White Brilliant Sparkle (Test product): 20% sodium bicarbonate</description>
        </group>
        <group group_id="E2">
          <title>Crest Cavity Protection Regular Toothpaste (Negative Control)</title>
          <description>2X daily brushing for 12 weeks with Crest Cavity Protection Regular Toothpaste (Negative Control)
Crest Cavity Protection Regular Toothpaste (Negative Control): Negative control</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="88"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="93"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="88"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="93"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Confidentiality agreement in place with Investigator.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Annahita Ghassemi</name_or_title>
      <organization>Church &amp; Dwight Co., Inc</organization>
      <phone>609-806-1884</phone>
      <email>annahita.ghassemi@churchdwight.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

